Increased intestinal permeability and downregulation of absorptive ion transporters Nhe3, Dra, and Sglt1 contribute to diarrhea during Clostridioides difficile infection

References

• Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–23. doi:10.1056/NEJMoa1408913.
   PubMed Web of Science ®Google Scholar
• CDC. Antibiotic resistance threats in teh United States. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. doi:10.15620/cdc:82532.
   Google Scholar
• Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020;382(14):1320–1330. doi:10.1056/NEJMoa1910215.
   PubMed Web of Science ®Google Scholar
• Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–2046. doi:10.1001/jamainternmed.2013.9763.
   PubMed Web of Science ®Google Scholar
• Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primer. 2016;2(1):1–20. doi:10.1038/nrdp.2016.20.
   Google Scholar
• Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46(3):447–450. doi:10.1086/525267.
   PubMed Web of Science ®Google Scholar
• Kordus SL, Thomas AK, Lacy DB. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. Nat Rev Microbiol. 2022;20(5):285–298. doi:10.1038/s41579-021-00660-2.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41(6):723–750. doi:10.1093/femsre/fux048.
   PubMed Web of Science ®Google Scholar
• Peritore-Galve FC, Shupe JA, Cave RJ, Childress KO, Washington MK, Kuehne SA, Lacy DB. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection. PLoS Pathog. 2022;18(2):e1010323. doi:10.1371/journal.ppat.1010323.
   PubMed Web of Science ®Google Scholar
• Carter GP, Chakravorty A, Nguyen TAP, Mileto S, Schreiber F, Li L, Howarth P, Clare S, Cunningham B, Sambol SP, et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. mBio. 2015;6(3):e00551. doi:10.1128/mBio.00551-15.
   PubMed Web of Science ®Google Scholar
• Mitchell TJ, Ketley JM, Haslam SC, Stephen J, Burdon DW, Candy DC, Daniel R. Effect of toxin a and B of Clostridium difficile on rabbit ileum and colon. Gut. 1986;27(1):78–85. doi:10.1136/gut.27.1.78.
   PubMed Web of Science ®Google Scholar
• Lyerly DM, Lockwood DE, Richardson SH, Wilkins TD. Biological activities of toxins a and B of Clostridium difficile. Infect Immun. 1982;35(3):1147–1150. doi:10.1128/iai.35.3.1147-1150.1982.
   PubMed Web of Science ®Google Scholar
• Taylor NS, Thorne GM, Bartlett JG. Comparison of two toxins produced by Clostridium difficile. Infect Immun. 1981;34(3):1036–1043. doi:10.1128/iai.34.3.1036-1043.1981.
   PubMed Web of Science ®Google Scholar
• Moore R, Pothoulakis C, LaMont JT, Carlson S, Madara JL. C. difficile toxin a increases intestinal permeability and induces Cl− secretion. Am J Physiol. 1990;259(2):G165–172. doi:10.1152/ajpgi.1990.259.2.G165.
   PubMedGoogle Scholar
• Mitchell TJ, Ketley JM, Burdon DW, Candy DCA, Stephen J. The effects of Clostridium difficile crude toxins and purified toxin a on stripped rabbit ileal mucosa in Ussing chambers. J Med Microbiol. 1987;23(3):199–204. doi:10.1099/00222615-23-3-199.
   PubMed Web of Science ®Google Scholar
• Triadafilopoulos G, Pothoulakis C, O’Brien MJ, LaMont JT. Differential effects of Clostridium difficile toxins a and B on rabbit ileum. Gastroenterology. 1987;93(2):273–279. doi:10.1016/0016-5085(87)91014-6.
   PubMed Web of Science ®Google Scholar
• Das S, Jayaratne R, Barrett KE. The role of ion transporters in the pathophysiology of infectious diarrhea. Cell Mol Gastroenterol Hepatol. 2018;6(1):33–45. doi:10.1016/j.jcmgh.2018.02.009.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Szászi K, Coady-Osberg N, Furuya W, Bretscher AP, Orlowski J, Grinstein S. Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B. J Gen Physiol. 2004;123(5):491–504. doi:10.1085/jgp.200308979.
   PubMed Web of Science ®Google Scholar
• Engevik MA, Engevik KA, Yacyshyn MB, Wang J, Hassett DJ, Darien B, Yacyshyn BR, Worrell RT. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile. Am J Physiol-Gastrointest Liver Physiol. 2014;308(6):G497–G509. doi:10.1152/ajpgi.00090.2014.
   PubMed Web of Science ®Google Scholar
• Coffing H, Priyamvada S, Anbazhagan AN, Salibay C, Engevik M, Versalovic J, Yacyshyn MB, Yacyshyn B, Tyagi S, Saksena S, et al. Clostridium difficile toxins a and B decrease intestinal SLC26A3 protein expression. Am J Physiol - Gastrointest Liver Physiol. 2018;315(1):G43–G52. doi:10.1152/ajpgi.00307.2017.
   PubMed Web of Science ®Google Scholar
• Janecke AR, Heinz-Erian P, Yin J, Petersen B-S, Franke A, Lechner S, Fuchs I, Melancon S, Uhlig HH, Travis S, et al. Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea. Hum Mol Genet. 2015;24(23):6614–6623. doi:10.1093/hmg/ddv367.
   PubMed Web of Science ®Google Scholar
• Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg M-L, Airola K, Holmberg C, de la Chapelle A, Kere J, et al. Mutations of the Down–regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat Genet. 1996;14(3):316–319. doi:10.1038/ng1196-316.
   PubMed Web of Science ®Google Scholar
• Gawenis LR, Stien X, Shull GE, Schultheis PJ, Woo AL, Walker NM, Clarke LL. Intestinal NaCl transport in NHE2 and NHE3 knockout mice. Am J Physiol Gastrointest Liver Physiol. 2002;282(5):G776–784. doi:10.1152/ajpgi.00297.2001.
   PubMed Web of Science ®Google Scholar
• Schweinfest CW, Spyropoulos DD, Henderson KW, Kim J-H, Chapman JM, Barone S, Worrell RT, Wang Z, Soleimani M. Slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J Biol Chem. 2006;281(49):37962–37971. doi:10.1074/jbc.M607527200.
   PubMed Web of Science ®Google Scholar
• Clayburgh DR, Musch MW, Leitges M, Fu Y-X, Turner JR. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest. 2006;116(10):2682–2694. doi:10.1172/JCI29218.
   PubMed Web of Science ®Google Scholar
• Erokhova L, Horner A, Ollinger N, Siligan C, Pohl P. The sodium glucose cotransporter SGLT1 is an extremely efficient facilitator of passive water transport. J Biol Chem. 2016;291(18):9712–9720. doi:10.1074/jbc.M115.706986.
   PubMed Web of Science ®Google Scholar
• Martín MG, Turk E, Lostao MP, Kerner C, Wright EM. Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet. 1996;12(2):216–220. doi:10.1038/ng0296-216.
   PubMed Web of Science ®Google Scholar
• Talbot C, Lytle C. Segregation of Na/H exchanger-3 and Cl/HCO3 exchanger SLC26A3 (DRA) in rodent cecum and colon. Am J Physiol-Gastrointest Liver Physiol. 2010;299(2):G358–G367. doi:10.1152/ajpgi.00151.2010.
   PubMed Web of Science ®Google Scholar
• Cha B, Tse M, Yun C, Kovbasnjuk O, Mohan S, Hubbard A, Arpin M, Donowitz M. The NHE3 juxtamembrane cytoplasmic domain directly binds ezrin: dual role in NHE3 trafficking and mobility in the brush border. Mol Biol Cell. 2006;17(6):2661–2673. doi:10.1091/mbc.e05-09-0843.
   PubMed Web of Science ®Google Scholar
• Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacherl J, Bischof G, Cosentini E, Feil W, Schiessel R, LaMont JT, et al. Clostridium difficile toxin B is more potent than toxin a in damaging human colonic epithelium in vitro. J Clin Invest. 1995;95(5):2004–2011. doi:10.1172/JCI117885.
   PubMed Web of Science ®Google Scholar
• Heyman M, Corthier G, Lucas F, Meslin JC, Desjeux JF. Evolution of the caecal epithelial barrier during Clostridium difficile infection in the mouse. Gut. 1989;30(8):1087–1093. doi:10.1136/gut.30.8.1087.
   PubMed Web of Science ®Google Scholar
• Chanez-Paredes SD, Abtahi S, Kuo W-T, Turner JR. Differentiating between tight junction-dependent and tight junction-independent intestinal barrier loss in vivo. Methods Mol Biol. 2021;2367:249–271.
   PubMedGoogle Scholar
• Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest. 2005;115(10):2702–2715. doi:10.1172/JCI24970.
   PubMed Web of Science ®Google Scholar
• Kang L, Fang X, Song Y-H, He Z-X, Wang Z-J, Wang S-L, Li Z-S, Bai Y. Neutrophil–epithelial crosstalk during intestinal inflammation. Cell Mol Gastroenterol Hepatol. 2022;14(6):1257–1267. doi:10.1016/j.jcmgh.2022.09.002.
   PubMed Web of Science ®Google Scholar
• Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin a perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest. 1988;82(5):1516–1524. doi:10.1172/JCI113760.
   PubMed Web of Science ®Google Scholar
• Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun. 2001;69(3):1329–1336. doi:10.1128/IAI.69.3.1329-1336.2001.
   PubMed Web of Science ®Google Scholar
• Mileto SJ, Jardé T, Childress KO, Jensen JL, Rogers AP, Kerr G, Hutton ML, Sheedlo MJ, Bloch SC, Shupe JA, et al. Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease. Proc Natl Acad Sci. 2020;117(14):8064–8073. doi:10.1073/pnas.1915255117.
   PubMed Web of Science ®Google Scholar
• Drewes JL, Chen J, Markham NO, Knippel RJ, Domingue JC, Tam AJ, Chan JL, Kim L, McMann M, Stevens C, et al. Human colon cancer–derived Clostridioides difficile strains drive colonic tumorigenesis in mice. Cancer Discov. 2022;12(8):1873–1885. doi:10.1158/2159-8290.CD-21-1273.
   PubMed Web of Science ®Google Scholar
• Marchelletta RR, Gareau MG, McCole DF, Okamoto S, Roel E, Klinkenberg R, Guiney DG, Fierer J, Barrett KE. Altered expression and localization of ion transporters contribute to diarrhea in mice with Salmonella-induced enteritis. Gastroenterology. 2013;145(6):1358–1368.e4. doi:10.1053/j.gastro.2013.08.054.
   PubMed Web of Science ®Google Scholar
• Hodges K, Gill R. Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes. 2010;1(1):4–21. doi:10.4161/gmic.1.1.11036.
   PubMed Web of Science ®Google Scholar
• Lehmann A, Hornby PJ. Intestinal SGLT1 in metabolic health and disease. Am J Physiol-Gastrointest Liver Physiol. 2016;310(11):G887–G898. doi:10.1152/ajpgi.00068.2016.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Inoue R, Matsumoto M, Yajima T, Ushida K, Iwanaga T. Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochem Cell Biol. 2011;135(2):183–194. doi:10.1007/s00418-011-0779-1.
   PubMed Web of Science ®Google Scholar
• González Bosc LV, Vidal NA, Prieto R, Tur JA. Effect of atrial natriuretic peptide on α-methyl-d-glucoside intestinal active uptake in rats. Peptides. 1998;19(7):1249–1253. doi:10.1016/S0196-9781(98)00072-2.
   PubMed Web of Science ®Google Scholar
• Honka H, Mäkinen J, Hannukainen JC, Tarkia M, Oikonen V, Teräs M, Fagerholm V, Ishizu T, Saraste A, Stark C, et al. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia. 2013;56(4):893–900. doi:10.1007/s00125-012-2825-5.
   PubMed Web of Science ®Google Scholar
• Antunes A, Martin-Verstraete I, Dupuy B. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol. 2011;79(4):882–899. doi:10.1111/j.1365-2958.2010.07495.x.
   PubMed Web of Science ®Google Scholar
• Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol. 1998;27(1):107–120. doi:10.1046/j.1365-2958.1998.00663.x.
   PubMed Web of Science ®Google Scholar
• Mefferd CC, Bhute SS, Phan JR, Villarama JV, Do DM, Alarcia S, Abel-Santos E, Hedlund BP. A high-fat/high-protein, atkins-type diet exacerbates Clostridioides (Clostridium) difficile infection in mice, whereas a high-carbohydrate diet protects. mSystems. 2020;5(1):e00765–19. doi:10.1128/mSystems.00765-19.
   PubMed Web of Science ®Google Scholar
• Engevik AC, Goldenring JR. Trafficking ion transporters to the apical membrane of polarized intestinal enterocytes. Cold Spring Harb Perspect Biol. 2018;10(1):a027979. doi:10.1101/cshperspect.a027979.
   PubMed Web of Science ®Google Scholar
• Kekuda R, Saha P, Sundaram U. Role of Sp1 and HNF1 transcription factors in SGLT1 regulation during chronic intestinal inflammation. Am J Physiol-Gastrointest Liver Physiol. 2008;294(6):G1354–G1361. doi:10.1152/ajpgi.00080.2008.
   PubMed Web of Science ®Google Scholar
• Malakooti J, Saksena S, Gill RK, Dudeja P. Transcriptional regulation of the intestinal luminal Na + and Cl − transporters. Biochem J. 2011;435(2):313–325. doi:10.1042/BJ20102062.
   PubMedGoogle Scholar
• Sundaram U, Wisel S, Rajendren VM, West AB. Mechanism of inhibition of Na+-glucose cotransport in the chronically inflamed rabbit ileum. Am J Physiol-Gastrointest Liver Physiol. 1997;273(4):G913–G919. doi:10.1152/ajpgi.1997.273.4.G913.
   Web of Science ®Google Scholar
• Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, et al. Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clin Vaccine Immunol. 2017;24(8):e00037–17. doi:10.1128/CVI.00037-17.
   PubMedGoogle Scholar
• Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171(11):6164–6172. doi:10.4049/jimmunol.171.11.6164.
   PubMed Web of Science ®Google Scholar
• Kumar A, Priyamvada S, Ge Y, Jayawardena D, Singhal M, Anbazhagan AN, Chatterjee I, Dayal A, Patel M, Zadeh K, et al. A novel role of SLC26A3 in the maintenance of intestinal epithelial barrier integrity. Gastroenterology. 2021;160(4):1240–1255.e3. doi:10.1053/j.gastro.2020.11.008.
   PubMed Web of Science ®Google Scholar
• Engevik AC, Kaji I, Engevik MA, Meyer AR, Weis VG, Goldstein A, Hess MW, Müller T, Koepsell H, Dudeja PK, et al. Loss of MYO5B leads to reductions in Na+ Absorption with maintenance of CFTR-Dependent Cl– Secretion in enterocytes. Gastroenterology. 2018;155(6):1883–1897.e10. doi:10.1053/j.gastro.2018.08.025.
   PubMed Web of Science ®Google Scholar
• Foulke-Abel J, In J, Yin J, Zachos NC, Kovbasnjuk O, Estes MK, de Jonge H, Donowitz M. Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology. 2016;150(3):638–649.e8. doi:10.1053/j.gastro.2015.11.047.
   PubMed Web of Science ®Google Scholar
• Kaji I, Roland JT, Watanabe M, Engevik AC, Goldstein AE, Hodges CA, Goldenring JR. Lysophosphatidic acid increases maturation of brush borders and SGLT1 activity in MYO5B-deficient mice, a model of microvillus inclusion disease. Gastroenterology. 2020;159(4):1390–1405.e20. doi:10.1053/j.gastro.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Ng YK, Ehsaan M, Philip S, Collery MM, Janoir C, Collignon A, Cartman ST, Minton NP. Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyre alleles. Plos One. 2013;8(2):e56051. doi:10.1371/journal.pone.0056051.
   PubMed Web of Science ®Google Scholar
• Kuehne SA, Minton NP. ClosTron-mediated engineering of Clostridium. Bioengineered. 2012;3(4):247–254. doi:10.4161/bioe.21004.
   PubMed Web of Science ®Google Scholar
• Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern. 1979;9(1):62–66. doi:10.1109/TSMC.1979.4310076.
   Web of Science ®Google Scholar
• Theriot CM, Koumpouras CC, Carlson PE, Bergin II, Aronoff DM, Young VB. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2011;2(6):326–334. doi:10.4161/gmic.19142.
   PubMed Web of Science ®Google Scholar
• Nik AM, Carlsson P. Separation of intact intestinal epithelium from mesenchyme. BioTechniques. 2013;55(1):42–44. doi:10.2144/000114055.
   PubMed Web of Science ®Google Scholar